Summary
Pruritus, or itching, is a common symptom that can arise from a broad spectrum of dermatologic and systemic conditions. Pruritus may be localized or generalized and can occur with or without primary skin lesions. Evaluation is guided by a focused history and physical examination, with laboratory testing used to assess for potential systemic etiologies. Management focuses on identifying and treating the underlying cause while providing symptomatic relief. The therapeutic approach is guided by clinical findings, with topical therapies commonly used for inflammatory or localized neuropathic causes, and systemic agents (such as gabapentinoids or immunosuppressants) considered for generalized or unclear etiologies.
Etiology
The cause of pruritus is often multifactorial.
Dermatologic causes [1][2]
- Inflammatory [3]
- Infectious
- Neoplastic (e.g., cutaneous T-cell lymphoma)
Nondermatologic causes [1][2]
Systemic
- Endocrine
-
Hepatic
- Cholestasis
- Primary biliary cholangitis
- Viral hepatitis (e.g., hepatitis C)
- Hematologic
- Renal: chronic kidney disease-associated pruritus
- Rheumatic
-
Neoplastic
- Leukemia
- Lymphoma
- Multiple myeloma
- Paraneoplastic syndromes due to solid tumors (e.g., prostate cancer, colorectal cancer)
-
Infections
- HIV infection
- Herpes zoster
- Parasitic infection (e.g., ascariasis, giardiasis, schistosomiasis, helminthiasis)
- Pregnancy-related
-
Medication-induced
- Opioids
- Antihypertensives (e.g., ACE inhibitors, hydrochlorothiazide)
- Statins (simvastatin)
- Nonsteroidal anti-inflammatory drugs
- Antibiotics (e.g., penicillins, trimethoprim/sulfamethoxazole)
- Cytostatic agents (e.g., paclitaxel, tamoxifen)
- Antimalarial drugs (chloroquine)
- Amiodarone
- Allopurinol
- Granulocyte-macrophage colony-stimulating factor
- Interleukin-2 agonists (aldesleukin)
- Hydroxyethyl starch
- Exogenous estrogens (e.g., hormone replacement therapy, transgender hormone treatment)
Neurologic
Psychiatric
Pathophysiology
- Poorly understood
- Trigger; , i.e., mechanical, chemical, or thermal stimuli, as well as exposure to certain mediators (e.g., histamine, serotonin, prostaglandins, kinins) → activation of afferent C-fibers in the skin → interpreted by the CNS as pruritus
- Scratching and rubbing the skin → stimulation of inhibitory circuits and pain receptors → decreased pruritus in the short-term (however, in many patients, scratching increases irritation and ultimately worsens itching)
- Gate control theory: Painful input transmitted by A-fibers inhibits the transmission of pruritic input from the C-fibers.
Clinical evaluation
Focused history [2]
-
Duration
- Acute (e.g., sunburn, allergic contact dermatitis)
- Chronic (> 6 weeks), e.g., psoriasis, atopic dermatitis
- Onset
-
Location
- Generalized distribution suggests a systemic cause.
- Localized distribution suggests a dermatologic or neuropathic cause.
- Presence or absence of skin lesions: Absence of lesions suggests a systemic rather than dermatologic cause.
- Triggers: : initiating factors such as contact allergens, insect bites, new medications, water exposure in polycythemia vera
- Symptoms suggestive of systemic cause, e.g.:
- Psychiatric history (including substance use)
- Travel and environmental history: may suggest infestation (e.g., scabies, lice).
- Family history of skin disorders (e.g., atopy)
Focused physical examination [2]
-
Skin examination: examination of scalp, nails, and anogenital area to assess
- Primary skin lesion
- Location: flexor surfaces in atopic dermatitis, extensor surfaces in psoriasis, interdigital spaces in scabies
- Changes as a result of scratching (secondary skin lesions)
- General examination: for signs of systemic disease (e.g., goiter in hyperthyroidism, jaundice in cholestasis)
- Neurological examination: focused examination of sensation for signs of peripheral neuropathy
Diagnosis
Approach [2][3]
Diagnostic evaluation depends on presentation and examination findings (e.g., presence or absence of primary skin lesions).
- If primary lesions are present and suggest an underlying diagnosis, proceed to empiric treatment.
- If primary lesions are absent, perform initial studies such as blood tests or imaging to help identify a systemic cause.
- Obtain additional studies (e.g., skin biopsy) if initial studies are inconclusive.
- If diagnosis remains unclear, consider specialist referral (e.g., dermatology or other specialist based on the suspected cause).
Generalized pruritus without primary skin lesions strongly suggests a systemic cause and warrants prompt evaluation for underlying medical conditions, including malignancy. [2]
Initial studies [2][3]
-
Blood tests
- CBC with differential: abnormal in hematologic or malignant disease, e.g., polycythemia vera, hemochromatosis, lymphoma
- Liver chemistries: elevated in cholestatic pruritus
- BMP: elevated in CKD-associated pruritus
- TSH levels can be elevated or decreased, as pruritus is associated with both hyperthyroidism and hypothyroidism.
- Diagnostic studies for iron deficiency anemia
- HbA1c: to identify pruritus associated with dermatophyte infections or diabetic neuropathy
- HIV serology [5]
- ESR may be elevated in systemic inflammatory conditions or malignancy.
- Imaging: chest x-ray to evaluate for malignancy
Additional studies [2]
If the diagnosis remains unclear after initial evaluation, further testing may be considered, often in consultation with a dermatologist.
- Skin biopsy: to evaluate for inflammatory, autoimmune, or neoplastic conditions
- Skin scrapings (e.g., KOH test): to evaluate for superficial fungal infections
- Culture: to identify bacterial, fungal, or atypical infections
Common causes
Dermatological causes of pruritus
| Common dermatological causes of pruritus [2][3] | ||||
|---|---|---|---|---|
| Condition | Characteristic clinical features | Diagnostic findings | Management | |
| Atopic dermatitis [6][7] |
|
|||
| Allergic contact dermatitis [8][9] |
|
|
|
|
| Xerosis cutis [2] |
|
|
||
| Scabies [4] |
|
|
|
|
| Urticaria [11] |
|
|
|
|
Systemic causes of pruritus
Treatment
Management involves treating the underlying cause and tailoring systemic or local therapies to clinical findings. [3]
-
General measures [2]
- Dry skin regimens (e.g., moisturizing ointments or emollients)
- Cool temperatures or wraps
- Brief, lukewarm showers and baths
-
Rash present and cause identified
- Inflammatory pruritus (e.g., atopic dermatitis, allergic contact dermatitis)
- Topical glucocorticoids (e.g., hydrocortisone, triamcinolone)
- Topical calcineurin inhibitors (e.g., tacrolimus, pimecrolimus)
- Topical biologics: ruxolitinib
- Infective pruritus: anti-infective medications (e.g., scabicidal agents for scabies)
- Inflammatory pruritus (e.g., atopic dermatitis, allergic contact dermatitis)
- Rash absent and systemic cause identified: Treat the systemic cause.
-
Rash absent and no systemic cause identified
- Neuropathic pruritus
- Localized: topical agents (e.g., capsaicin, topical anesthetics)
- Generalized: gabapentinoids, antidepressants (e.g., sertraline), opioid receptor antagonists (e.g., naltrexone)
- Inflammatory or mixed etiology pruritus
- Localized: topical agents (e.g., topical glucocorticoids)
- Generalized: biologic agents, phototherapy, systemic immunosuppressants (e.g., oral corticosteroids)
- Neuropathic pruritus